VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > time line

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Dec 06, 2021 4:11pm

129 Views

Post# 34203659

RE:time line

bluemoons20 wrote: All of this 'good' news seems to be being read by the market as an indication that the timeline to buyout is not 'right around the corner'.

there is a lot more work to be done to get this to a stage that it might be adopted. Hence, every day , even good news leads to a drop in price from folks leaving to take up other more timely opportunities.

they may come back after more development, but for now , it looks like they are deserting the ship.

Anyone have any other ideas??

GLTA

It's all in Dr. Adams hands and that pile of news items he has on his desk.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario